NeueHealth, Inc. (NYSE:NEUE) Short Interest Up 33.7% in March

NeueHealth, Inc. (NYSE:NEUE) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 12,300 shares, an increase of 33.7% from the February 28th total of 9,200 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily volume of 47,300 shares, the days-to-cover ratio is presently 0.3 days.

NeueHealth Stock Performance

NYSE NEUE traded down $0.16 on Tuesday, hitting $6.60. The stock had a trading volume of 20,751 shares, compared to its average volume of 19,981. The firm has a 50-day moving average of $6.92 and a 200-day moving average of $6.09. NeueHealth has a 52-week low of $3.79 and a 52-week high of $7.66. The company has a market capitalization of $54.68 million, a price-to-earnings ratio of -0.13 and a beta of 0.56.

NeueHealth (NYSE:NEUE) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($7.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.29) by ($5.12). NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. The business had revenue of $232.64 million during the quarter, compared to analysts’ expectations of $261.80 million. As a group, research analysts anticipate that NeueHealth will post -9.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada decreased their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

Insider Buying and Selling at NeueHealth

In other news, CFO Jay Matushak sold 4,448 shares of NeueHealth stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at approximately $280,330.08. The trade was a 9.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO George Lawrence Mikan III sold 31,798 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $233,079.34. Following the sale, the chief executive officer now directly owns 146,539 shares in the company, valued at $1,074,130.87. This trade represents a 17.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 110,033 shares of company stock valued at $774,560 over the last three months. 64.30% of the stock is currently owned by insiders.

Institutional Trading of NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Virtu Financial LLC bought a new stake in shares of NeueHealth, Inc. (NYSE:NEUE) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned about 0.12% of NeueHealth at the end of the most recent reporting period. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.